Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ0,00
KB0,00
PKN107,9108,2-1,92
Msft-0,13
Nokia5,8665,921,16
IBM1,10
Mercedes-Benz Group AG57,5857,60,89
PFE0,40
14.02.2026 2:04:00
Indexy online
AD Index online
select
AD Index online
 

  • 16.12.2025 19:51:02
Integer Holdings (Frankfurt)
Závěr k 13.2.2026 Změna (%) Změna (EUR) Objem obchodů (EUR)
71,50 0,70 0,50 6 930
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace:
Popis společnosti
Obecné informace
Název společnostiInteger Holdings Corp
TickerITGR
Kmenové akcie:Ordinary Shares
RICITGR.K
ISIN-
Poslední známé roční výsledky31.12.2024
Poslední známé čtvrtletní výsledky26.09.2025
Počet zaměstnanců k 31.12.2024 11 000
Akcie v oběhu k 17.10.2025 35 038 426
MěnaUSD
Konstituent indexůS&P 600 Small Cap
Kontaktní informace
Ulice5830 Granite Parkway., Suite 1150
MěstoPLANO
PSČ75024
ZeměUnited States
Kontatní osobaAndrew Senn
Funkce kontaktní osobySenior Vice President - Strategy, Business Development and Investor Relations
Telefon12 146 185 243
Fax13026555049
Kontatní telefon1763951-8312

Business Summary: Integer Holdings Corporation is a medical device contract development and manufacturing company. The Company serves the cardiac rhythm management, neuromodulation, and cardio and vascular markets. Its brands include Greatbatch Medical and Lake Region Medical. The Company’s Cardio & Vascular product line offers a range of components, subassemblies, and finished devices used in interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, urology, and gastroenterology procedures. Its interventional cardiology portfolio is focused primarily on the design, development and manufacture of catheter and wire-based technologies intended to diagnose and treat cardiac disease. Its electrophysiology products include devices used by electrophysiologists and interventional cardiologists for the treatment of cardiac arrythmias, such as atrial fibrillation.
Financial Summary: BRIEF: For the 38 weeks ended 26 September 2025, Integer Holdings Corp revenues increased 9% to $1.38B. Net income before extraordinary items decreased 38% to $54.2M. Revenues reflect Cardio & Vascular segment increase from $241M to $822.9M, Cardiac Rhythm Management & Neuromodulation segment increase from $165.1M to $501.5M, Rest of the world segment increase of 18% to $653.8M, United States segment increase of less than 1% to $727.8M.
Odvětvová klasifikace
TRBC2009Advanced Medical Equipment
TRBC2012Advanced Medical Equipment & Technology (NEC)
RBSS2004Advanced Medical Equipment
MGINDUSTRYMedical Equipment & Supplies
MGSECTORHealthcare
NAICSElectromedical and Electrotherapeutic Apparatus Manufacturing
NAICSSurgical and Medical Instrument Manufacturing
NAICSSurgical Appliance and Supplies Manufacturing
NAICSBattery Manufacturing
NAICSAll Other Miscellaneous Electrical Equipment and Component Manufacturing
NAICSLessors of Nonfinancial Intangible Assets (except Copyrighted Works)
NAICSResearch and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
NAICSCapacitor, Resistor, Coil, Transformer, and Other Inductor Manufacturing
NAICS2007Electromedical Apparatus Mfg
NAICS2007Surgical & Medical Instrument Mfg
NAICS2007Primary Battery Mfg
NAICS1997Electromedical and Electrotherapeutic Apparatus Manufacturing
NAICS1997Surgical and Medical Instrument Manufacturing
NAICS1997Dry and Wet Primary Battery Manufacturing
SICElectromedical Equipment
SICSurgical And Medical Instruments
SICStorage Batteries
SICSurgical Appliances And Supplies
SICElectrical Equip/supplies, Nec
SICPatent Owners And Lessors
SICCommercial Physical Research
SICElectronic Coils And Transformers



  • Poslední aktualizace:
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
President, Chief Executive Officer, DirectorPayman Khales5524.10.202520.02.2018
Chief Financial Officer, Executive Vice PresidentDiron Smith5209.10.202308.05.2023
President - Cardiac Rhythm Management & NeuromodulationJim Stephens51
Executive Vice President, Chief Human Resources OfficerKirk Thor6102.01.201802.01.2018
Executive Vice President - Quality and Regulatory AffairsMargaret Carthy61
Executive Vice President - Global Operations and Manufacturing StrategyJohn Harris65
Senior Vice President - Strategy, Business Development and Investor RelationsAndrew Senn43